Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenwei Peng

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2022
pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumorsRui Sun, Wen Ma, Mingjian Ling, et al.
Biochemical and Biophysical Research Communications|September 10, 2017
Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinomaZebin Chen, Lixia Xu, Tianhong Su, et al.
Human Vaccines & Immunotherapeutics|August 17, 2022
COVID-19 vaccination perception and uptake among cancer patients in Guangzhou, ChinaLeiwen Fu, Shuang Wu, Bingyi Wang, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Combination locoregional and systemic therapies in hepatocellular carcinomaBin-Yan Zhong, Wenzhe Fan, Justin J Guan, et al.
Advanced Healthcare Materials|September 4, 2023
Size-Tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular CarcinomaYuhao Tang, Zhilin Shu, Meiyan Zhu, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 26, 2022
The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasionZhenwei Peng, Xiaoxue Wu, Jiaping Li, et al.
Redox Biology|March 6, 2021
Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivoYifeng Luo, Gang Niu, Hui Yi, et al.
Optics Express|June 14, 2025
High-spatial-resolution quasi-distributed acoustic sensing with phase noise suppression based on φ-OFDRHuajian Zhong, Zhenwei Peng, Yuhao Kong, et al.
JAMA Oncology|June 20, 2024
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical TrialWenzhe Fan, Bowen Zhu, Shuling Chen, et al.
International Journal of Surgery (London, England)|November 5, 2016
Salvage resection for recurrent or metastatic hepatocellular carcinoma after percutaneous ablation therapyWenjie Hu, Zhenwei Peng, Dongming Li, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 2, 2022
pH-activated nanoplatform for visualized photodynamic and ferroptosis synergistic therapy of tumorsRui Sun, Wen Ma, Mingjian Ling, et al.
Biochemical and Biophysical Research Communications|September 10, 2017
Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinomaZebin Chen, Lixia Xu, Tianhong Su, et al.
Human Vaccines & Immunotherapeutics|August 17, 2022
COVID-19 vaccination perception and uptake among cancer patients in Guangzhou, ChinaLeiwen Fu, Shuang Wu, Bingyi Wang, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Combination locoregional and systemic therapies in hepatocellular carcinomaBin-Yan Zhong, Wenzhe Fan, Justin J Guan, et al.
Advanced Healthcare Materials|September 4, 2023
Size-Tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular CarcinomaYuhao Tang, Zhilin Shu, Meiyan Zhu, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 26, 2022
The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasionZhenwei Peng, Xiaoxue Wu, Jiaping Li, et al.
Redox Biology|March 6, 2021
Nanomedicine promotes ferroptosis to inhibit tumour proliferation in vivoYifeng Luo, Gang Niu, Hui Yi, et al.
Optics Express|June 14, 2025
High-spatial-resolution quasi-distributed acoustic sensing with phase noise suppression based on φ-OFDRHuajian Zhong, Zhenwei Peng, Yuhao Kong, et al.
JAMA Oncology|June 20, 2024
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical TrialWenzhe Fan, Bowen Zhu, Shuling Chen, et al.
International Journal of Surgery (London, England)|November 5, 2016
Salvage resection for recurrent or metastatic hepatocellular carcinoma after percutaneous ablation therapyWenjie Hu, Zhenwei Peng, Dongming Li, et al.
Pageof 11